COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,401 Articles (22,816 medRxiv, 8,585 bioRxiv)

Most recent first Previous |  Page 652: Articles 6511-6520  | Next

Comparative multi-OMICS single-cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action
Singh, Y., Schulze-Selting, A., Gabernet, G., Ray, U., Bajaj, R., Ali, M., Loitz, M., Hammer, V., Buena-Atienza, E., Ruschil, C., Huebner, J., Kowarik, M., salker, M., Casadei, N., Nahnsen, S., Kremsner, P., Ossowski, S., Altmann, D. M., Deutsche COVID-19 OMICS Initiative (DeCOI), , Riess, O.
10.1101/2022.09.12.507666 — Posted: 2022-09-13
Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA Vaccine in Rhesus Macaques (Macaca mulatta) Delivered using Needle-free Jet Injection
Jay, A., Kwilas, S. A., Josleyn, M., Ricks, K., Hooper, J. W.
10.1101/2022.09.12.507647 — Posted: 2022-09-13
Evaluation of endogenous and therapeutic 25-hydroxycholesterols in murine models of pulmonary SARS-CoV-2 infection
Fessler, M. B., Madenspacher, J., Baker, P. J., Hilligan, K. L., Castro, E., Meacham, J., Chen, S.-H., Johnson, R. F., Martin, N. P., Tucker, C. J., Mahapatra, D., Cesta, M., Mayer-Barber, K. D.
10.1101/2022.09.12.507671 — Posted: 2022-09-13
A general theory for infectious disease dynamics.
Carbone, G., De Vincenzo, I.
10.1101/2022.09.12.22278744 — Posted: 2022-09-13
The SARS-CoV-2 Spike Protein Mutation Explorer: Using an Interactive Application to Improve the Public Understanding of SARS-CoV-2 Variants of Concern
Iannucci, S., Harvey, W. T., Hughes, J., Robertson, D. L., Poyade, M., Hutchinson, E.
10.1101/2022.09.09.507349 — Posted: 2022-09-12
Determinants restricting ACE2 recognition of MERS-related coronaviruses in bats
Ma, C., Xiong, Q., Gu, M., Wang, C., Shi, L., Liu, C., Si, J., Tong, F., Liu, P., Huang, M., Yan, H.
10.1101/2022.09.11.507506 — Posted: 2022-09-12
Clomipramine inhibits dynamin L-α-phosphatidyl-L-serine stimulated GTPase activity
Miyoshi, H., Otomo, M., Takahashi, K.
10.1101/2022.09.09.507370 — Posted: 2022-09-12
Multicentre diagnostic evaluation of OnSite COVID-19 Rapid Test (CTK Biotech) among symptomatic individuals in Brazil and The United Kingdom
Thompson, C. R., Torres, P. M., Kontogianni, K., Bengey, D., Byrne, R. L., Noguera, S. V., Luna-Muschi, A. J., Andrade, P. S., dos Santos Barboza, A., Nishikawara, M., Body, R., de Vos, M., Escadafal, C., Adams, E. R., Costa, S. F., Cubas Atienzar, A. I.
10.1101/2022.09.12.22279847 — Posted: 2022-09-12
Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: A data linkage study
Cowley, L. E., Hodgson, K., Song, J., Whiffen, T., Tan, J., John, A., Bandyopadhyay, A., Davies, A. R.
10.1101/2022.09.11.22279823 — Posted: 2022-09-12
MAM: Flexible Monte-Carlo Agent-based Model for Modelling COVID-19 Spread
De-Leon, H., Aran, D.
10.1101/2022.09.11.22279815 — Posted: 2022-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).